"L'ospedale di riferimento della AZIENDA UNITA' SANITARIA LOCALE DI PIACENZAcomprende al suo interno diversi reparti specialistici come ad esempio la chirurgia generale e toracica, Medicina generale, Oncologia, Ematologia, Terapia intensiva e del Dolore. Tutti i reparti di ricovero e gli ambulatori sono supportati nelle loro attività da un dettagliato reparto di Radiologia e Anestesiologia che possono intervenire con competenza nelle situazioni più complesse e aiutare il settore delle visite ambulatoriali con immagini radiografiche, tac e risonanze magnetiche aperte e non, operando con macchinari moderni e usufruendo delle più recenti tecnologie in materia."

During the past decade, Ospedale Guglielmo da Saliceto conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 18 clinical trials were completed, i.e. on average, 41.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 11 clinical trials were completed. i.e. 68.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Guglielmo da Saliceto" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 7 trials, followed by "Gruppo Italiano Trapianto di Midollo Osseo" with 7 trials sponsored, "Mario Negri Institute for Pharmacological Research" with 6 trials sponsored, "Gilead Sciences" with 5 trials sponsored and "Boehringer Ingelheim" with 5 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Guglielmo da Saliceto" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator, "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials as a collaborator and "Gruppo Oncologico Italiano di Ricerca Clinica" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Guglielmo da Saliceto" are "Multiple Myeloma" (5 trials), "Cancer Pain" (3 trials), "Acute Coronary Syndrome" (2 trials), "Atrial Fibrillation" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Ospedale Guglielmo da Saliceto" in a lesser frequency.

Most popular intervention types in "Ospedale Guglielmo da Saliceto" are "Drug" (65 trials), "Other" (8 trials), "Device" (4 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (4 trials), "Dexamethasone" (3 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials) and "cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Guglielmo da Saliceto" are 80 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Guglielmo da Saliceto". undefined are not yet recruiting, 7 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Ospedale Guglielmo da Saliceto, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Guglielmo da Saliceto, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".